Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 31, Issue 3, 2014, Pages 191-197

  Agabiti, Nera ^b   Porretta, Maria Assunta ^a   Bauleo, Lisa ^b   Coppola, Angelo ^a   Sergiacomi, Gianluigi ^a   Fusco, Armando ^a   Cavalli, Francesco ^a   Zappa, Maria Cristina ^c   Vignarola, Rossana ^c   Carlone, Stefano ^d   Facchini, Giampiero ^d   Mariotta, Salvatore ^e   Palange, Paolo ^f   Valente, Salvatore ^a   Pasciuto, Giovanna ^a   Pezzuto, Gabriella ^a   Orlandi, Augusto ^a   Fusco, Danilo ^b   Davoli, Marina ^b   Saltini, Cesare ^a   Puxeddu, Ermanno ^a   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^c SANDRO PERTINI HOSPITAL   (Italy)

^d SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f POLICLINICO UMBERTO I   (Italy)

Author keywords

Epidemiology; Icd9 cm; Idiopathic pulmonary fibrosis

Indexed keywords

ADULT; AGED; ARTICLE; BIOMEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; FIBROSING ALVEOLITIS; HEALTH SERVICE; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; ICD-9-CM; INCIDENCE; INTERSTITIAL LUNG DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MIDDLE AGED; PNEUMOCONIOSIS; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RADIOLOGIST; RANDOM SAMPLE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SOUTHERN EUROPEAN; YOUNG ADULT; ADOLESCENT; CLINICAL TRIAL; FACTUAL DATABASE; HEALTH SURVEY; HOSPITAL ADMISSION; IDIOPATHIC PULMONARY FIBROSIS; MORTALITY; MULTICENTER STUDY; TIME FACTOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH SURVEYS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84922179143     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ATS/ERS/JRS/ALAT. Idiopathic Pulmonary Fibrosis: Evidencebased Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011;183:788-824.
2. Gribbin J, Hubbard RB, Le Jeune I et Al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980-985.
3. Mura M, Porretta MA, Bargagli E et Al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study. Eur Respir J 2012;40(1):101-9.
4. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979-1991: An analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996;153:1548-1552.
5. Raghu G, Freudenberger TD, Yang S .et Al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-142.
6. Raghu G, Weycker D, Edelsberg J, et Al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
7. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000;161:1172-1178.
8. King TE Jr, Tooze JA, Schwarz MI et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.
9. Coultas DB, Zumwalt RE, Black WC et al.The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
10. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
11. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008;3:8.
12. Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:285-292.
13. Xaubet A, Ancochea J, Morell F et al. Report on the incidence of interstitial lung disease in Spain. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:64-70.
14. Karakatsani A, Papakosta D, Rapti A et al. Epidemiology of interstitial lung diseases in Greece. Resp Med 2009;103:1122-1129.
15. Von Plessen C, Grinde O, Gulsvik A.. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med 2003;97(4):428-35.
16. Tinelli C, De Silvestri A, Richeldi L et al. The Italian register for diffuse infiltrative lung disorders (RIPID): A four-year report. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:4-8.
17. Coultas DB, Zumwalt RE, Black WC et al.The epidemiology of interstitial lung disease. Am J Respir Crit Care Med 1994;50:967-972.
18. Roelandt M, Demedts M, Callebaut W, et al. Working group on ILD. Epidemiology of interstitial lung diseases in Flanders: registration by pneumologists in 1992-1994. Acta Clin Belg 1995;50-55: 260-268.
19. Thomeer M, Demedts M, Vandeurzen K, et al. Epidemiological registration of interstitial lung diseases. Am J Respir Crit Care Med 1997;155:A320.
20. Thomeer M, Demedts M, Vandeurzen K, et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders Acta Clin Belg 2001;56:163-172.
21. Schweisfurth H, Costabel U, Kropp R et al. Mitteilung der wissenschaftliches Arbeitsgemeinschaft für die Therapie von Lungenkrankheiten (WATL): Deutsches Fibroseregister mit ernsten Ergebnissen. Pneumologie 1996; 50:899-901.
22. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic polmonar fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002;57: 338-342.
23. Navaratnam V, Fleming KM, West J et al.The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 201;66(6):462-7.
24. Cesaroni G, Agabiti N, Forastiere F et al. Socioeconomic differences in stroke incidence and prognosis under a universal healthcare system. Stroke 2009;40:2812-2819.
25. Navaratnam V, Fogarty A, Glendening R et al. The increasing secondary care burden of idiopathic pulmonary fibrosis:Hospital admission trends in England from 1998 to 2010. Chest 2013; 143(4): 1078-1084.
26. Kornum JB, Christensen S, Grijota M et al. The incidence of interstitial lung disease 1995-2005: A Danish nationwide populationbased study. BMC Pulm Med 2008;8:24.
27. Agabiti N, Belleudi V, Davoli M et al. Profiling hospital performance to monitor the quality of care: The case of COPD. Eur Respir J 2010;35:1031-1038.
28. Fernández Pérez ER, Daniels CE, Schroeder DR et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest 2010;137(1):129-37.
29. Lai CC, Wang CY, Lu HM et al. Idiopathic pulmonary fibrosis in Taiwan - A population-based study. Respir Med 2012;106(11):1566-74.
30. Arndt H, King TK, Briscoe WA. Diffusing capacities and ventilation- perfusion ratios in patients with the clinical syndrome of alveolar capillary block. J Clin Invest 1970;49(2):408-22.
31. Pompeo E, Rogliani P, Cristino B et al. Awake thoracoscopic biopsy of interstitial lung disease. Ann Thorac Surg 2013;95(2):445-52.
32. Flaherty KR, King TE, Raghu G et al. Idiopathic interstitial pneumoniae: what is the effect of a Multidisciplinary diagnosis Am J Respir Crit Care Med 2004;107(8):904-10.
33. Flaherty KR, Andrei AC, King TE et al. Do Community and Academic Physicians Agree on Diagnosis. Am J Respir Crit Care Med 2007;175(10):1054-60.
34. An official American Thoracic Society/European Respiratory Society statement. Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733-48.
35. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013;25(5):483-492.
36. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006;3(4):293-298.
37. Johnston ID, Prescott RJ, Chalmers JC et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 1997;52(1):38-44.
38. Johnston I, Britton J, Kinnear W et al. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301(6759):1017-1021.
39. Kitamura H, Ichinose S, Hosoya T et al. Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis - elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. Pathol Res Pract 2007;203(8):575-585.